A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
NCT04844840
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Keloid
Interventions
DRUG:
STP705
OTHER:
Placebo
Sponsor
Sirnaomics